Unfortunately, as the shortage of Adderall announced by the Food and Drug Administration in October 2022 continues, more Americans have been feeling that "crushing weight." These delays have been attributed to supply chain and manufacturing issues ...
Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for the antipsychotic clozapine.